Risk factors for infantile hemangioma: a meta-analysis
- PMID: 31853885
- DOI: 10.1007/s12519-019-00327-2
Risk factors for infantile hemangioma: a meta-analysis
Abstract
Background: Infantile hemangioma (IH) is one of the most common tumors in infants. Its pathogenesis is complex and poorly understood. The risk factors of IH have been extensively studied from clinical and epidemiological perspectives in recent years, but the conclusions in the literature reports are inconsistent. To provide a reference for the prevention of hemangioma, we conducted a meta-analysis of the published studies of potential risk factors for IH.
Methods: The Cochrane Library, Ovid, PubMed, and Web of Science databases were searched systematically. Log odds ratios (log ORs), logistic regression standard errors and 95% confidence intervals (CIs) were used to compare the correlation between IH and potential risk factors. Review Manager 5.3.3 was used for the statistical analysis.
Results: Six studies were included and 17 potential risk factors were eventually evaluated. P values < 0.05 were found for female gender (P < 0.01, OR 2.04, 95% CI 1.65-2.51), low birth weight (P < 0.01, OR 4.39, 95% CI 3.05-6.31), multiple gestation (P = 0.01, OR 2.39, 95% CI 1.21-4.71), preterm birth (P = 0.03, OR 2.37, 95% CI 1.07-5.23), progesterone therapy (P < 0.01, OR 2.73, 95% CI 2.12-3.51), and family history (P = 0.01, OR 1.98, 95% CI 1.16-3.38).
Conclusions: This meta-analysis revealed that risk factors, including female gender, low birth weight, multiple gestation, preterm birth, progesterone therapy, and family history may affect the occurrence of IH.
Keywords: Infantile hemangioma; Meta-analysis; Risk factors.
Similar articles
-
Tocolysis with the β2-sympathomimetic fenoterol does not increase the occurrence of infantile hemangioma in preterm and term infants.Arch Gynecol Obstet. 2018 Sep;298(3):521-527. doi: 10.1007/s00404-018-4830-5. Epub 2018 Jun 25. Arch Gynecol Obstet. 2018. PMID: 29938346
-
Clinical and epidemiological risk factors for infantile hemangioma: A case-control study.Pediatr Dermatol. 2023 Jul-Aug;40(4):647-650. doi: 10.1111/pde.15363. Epub 2023 Jun 14. Pediatr Dermatol. 2023. PMID: 37314056
-
Maternal and perinatal risk factors for infantile hemangioma: a case-control study.Pediatr Dermatol. 2013 Jul-Aug;30(4):457-61. doi: 10.1111/pde.12042. Epub 2012 Dec 26. Pediatr Dermatol. 2013. PMID: 23278441
-
Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment.Birth Defects Res. 2017 Jul 3;109(11):809-815. doi: 10.1002/bdr2.1023. Epub 2017 Apr 12. Birth Defects Res. 2017. PMID: 28402073 Free PMC article. Review.
-
Effect of topical timolol on response rate and adverse events in infantile hemangioma: a meta-analysis.Arch Dermatol Res. 2018 May;310(4):261-269. doi: 10.1007/s00403-018-1815-y. Epub 2018 Jan 23. Arch Dermatol Res. 2018. PMID: 29362868 Review.
Cited by
-
Global research trends of infantile hemangioma: A bibliometric and visualization analysis from 2000 to 2022.Heliyon. 2023 Oct 21;9(11):e21300. doi: 10.1016/j.heliyon.2023.e21300. eCollection 2023 Nov. Heliyon. 2023. PMID: 37920523 Free PMC article.
-
Malignant and Benign Head and Neck Tumors of the Pediatric Age: A Narrative Review.Curr Pediatr Rev. 2025;21(2):118-132. doi: 10.2174/0115733963258575231123043807. Curr Pediatr Rev. 2025. PMID: 38310547 Review.
-
Infantile hemangioma: the common and enigmatic vascular tumor.J Clin Invest. 2024 Apr 15;134(8):e172836. doi: 10.1172/JCI172836. J Clin Invest. 2024. PMID: 38618963 Free PMC article. Review.
-
Oral propranolol and its impact on vital signs in hospitalized pediatric patients for the Management of Infantile Hemangiomas.Pediatr Dermatol. 2025 Mar-Apr;42(2):245-250. doi: 10.1111/pde.15740. Epub 2025 Feb 18. Pediatr Dermatol. 2025. PMID: 39963769 Free PMC article.
-
Management of infantile hemangiomas: Recent advances.Front Oncol. 2022 Nov 29;12:1064048. doi: 10.3389/fonc.2022.1064048. eCollection 2022. Front Oncol. 2022. PMID: 36523969 Free PMC article. Review.
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical